2022 TRIAL INNOVATION NETWORK (TIN) LECTURE SERIES
“Methodologic Innovations in Study Design: A Randomized Selection Trial for Prevention of Chemotherapy Induced Peripheral Neuropathy”
MELISSA ACCORDINO, MD
Assistant Professor Department of Medicine
Medical Hematology & Oncology Columbia University
This talk will highlight a novel randomized selection design in a phase II trial. The objective of this study was to determine which of three strategies (cryotherapy, compression therapy, placebo) had the highest probability of success in a future phase III study to prevent chemotherapy induced peripheral neuropathy.
Tuesday, March 22, 2022 - 12:00 to 1:00 PM
Presented on behalf of the Irving Institute for Clinical and Translational Research
